Highlights
NASDAQ: FATE       Fate Therapeutics
Last Price Today's Change   Day's Range   Trading Volume
48.36   +0.65 (1.36%)  47.06 - 48.595  319,600

Overview

 
Avg Volume (4 weeks):975,640
4 Weeks Range:35.80 - 51.10
4 Weeks Price Volatility (%):
82.09%
52 Weeks Range:12.59 - 51.10
52 Weeks Price Volatility (%):
92.88%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company which develops programmed cellular immunotherapies for cancer and immune disorders. It uses pharmacologic modulators, such as small molecules, to enhance the biological properties and therapeutic function of cells ex vivo before the product candidates are administered to a patient. In other cases, it uses human induced pluripotent stem cells (iPSCs), generates a master iPSC line having preferred biological properties, and direct the fate of the iPSC line to create a clonal population.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

4328  4069  664  210 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 SNAP 43.17+4.20 
 SCKT 2.55+1.09 
 GE 7.63-0.09 
 INTC 48.20-5.70 
 AAL 12.60-0.55 
 MRIN 3.45+1.33 
 AAPL 115.04-0.71 
 OAS 0.155-0.014 
 F 8.16-0.05 
 NIO 27.16-0.22